The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
A correction has been published: N Engl J Med 2005;352(22):2362.

Original Article
Brief Report
PreviousPrevious
Volume 352:1557-1564 April 14, 2005 Number 15
NextNext

Modification of Human Hearing Loss by Plasma-Membrane Calcium Pump PMCA2
Julie M. Schultz, Ph.D., Yandan Yang, Ph.D., Ariel J. Caride, Ph.D., Adelaida G. Filoteo, B.S., Alan R. Penheiter, Ph.D., Ayala Lagziel, Ph.D., Robert J. Morell, Ph.D., Saidi A. Mohiddin, M.D., Ph.D., Lameh Fananapazir, M.D., Anne C. Madeo, M.S., John T. Penniston, Ph.D., and Andrew J. Griffith, M.D., Ph.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-PowerPoint Slide Set
-Supplementary Material

Commentary
-Editorial
 by Nadeau, J. H.

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
-PubMed Citation
SUMMARY

Five adult siblings presented with autosomal recessive sensorineural hearing loss: two had high-frequency loss, whereas the other three had severe-to-profound loss affecting all frequencies. Genetic evaluation revealed that a homozygous mutation in CDH23 (which encodes cadherin 23) caused the hearing loss in all five siblings and that a heterozygous, hypofunctional variant (V586M) in plasma-membrane calcium pump PMCA2, which is encoded by ATP2B2, was associated with increased loss in the three severely affected siblings. V586M was detected in two unrelated persons with increased sensorineural hearing loss, in the other caused by a mutation in MYO6 (which encodes myosin VI) in one and by noise exposure, suggesting that this variant may modify the severity of sensorineural hearing loss caused by a variety of factors.


Source Information

From the Section on Human Genetics (J.M.S., A.L., R.J.M.), the Section on Gene Structure and Function (Y.Y., A.J.G.), and the Hearing Section (A.C.M., A.J.G.), National Institute on Deafness and Other Communication Disorders, and the Cardiovascular Branch, National Heart, Lung, and Blood Institute (S.A.M., L.F.), National Institutes of Health, Rockville and Bethesda, Md.; the Department of Biochemistry and Molecular Biology (A.J.C., A.G.F.) and the Department of Anesthesiology (A.R.P.), Mayo Foundation, Rochester, Minn.; and the Neuroscience Center, Massachusetts General Hospital and Harvard Medical School, Boston (J.T.P.).

Address reprint requests to Dr. Griffith at the NIDCD, National Institutes of Health, 5 Research Ct., Rm. 2A-01, Rockville, MD 20850, or at griffita{at}nidcd.nih.gov.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.